Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Daflon for grade 1 and 2 hemorrhoids
IRCT20250512065701N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of diosmin in hemorrhoid (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Recovery time, Wound size and 2 more. Started Jun 2025; status: completed.
02
Drugs
diosmin
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on IRCT20250512065701N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250512065701N1.